Who owns ImmunoGen?

Key details on ImmunoGen (Ticker: IMGN)

Who owns ImmunoGen?

Is IMGN a good stock to own? Find out who bought ImmunoGen, who sold ImmunoGen (IMGN) stock, and who holds a large position in ImmunoGen.

Fund Name Number of Shares Share Valuation As Of
PRIMECAP Management Company 12.13M $73.98M Dec. 31, 2014
ClearBridge Advisors 11.44M $69.76M Dec. 31, 2014
FMR 10.26M $108.66M Sept. 30, 2014
First Trust Advisors 5.81M $61.55M Sept. 30, 2014
Vanguard 5.31M $32.39M Dec. 31, 2014
BB Biotech AG 3.24M $19.77M Dec. 31, 2014
BlackRock Fund Advisors 3.18M $19.40M Dec. 31, 2014
STATE STREET CORPORATION 3.14M $19.16M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 2.42M $14.79M Dec. 31, 2014
Sectoral Asset Management 2.27M $24.04M Sept. 30, 2014
OrbiMed Advisors 1.93M $28.14M Sept. 30, 2012
Artal Group S.A. 1.90M $20.12M Sept. 30, 2014
Millennium Management 1.83M $11.13M Dec. 31, 2014
Wellington Management Company 1.31M $15.49M June 30, 2014
Gail Mannix 1.24M $7.56M Dec. 31, 2014
NORTHERN TRUST 1.23M $18.00M Dec. 31, 2013

Who sold ImmunoGen?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management Dec. 31, 2013 2.37M $34.81M
Maverick Capital Dec. 31, 2000 1.57M $33.57M